Vertex Pharmaceuticals | VRTX - حساب الفائدة على الديون





حساب الفائدة على الديون تغيير تاريخ
AbbVie USD 688M 58M 2026-09
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
Amgen USD 653M 94.99B 2026-09
Arrowhead Research USD 24.56M 716K 2026-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Bristol-Myers Squibb USD 403M 4M 2026-09
Gilead Sciences USD 269M 22M 2026-09
Incyte USD 605K 23K 2026-09
Insmed USD 20.41M 1.57M 2026-09
Ionis Pharmaceuticals USD 4M 14M 2026-09
J&J USD 43M 25M 2026-03
Merck USD 525M 46M 2026-06
Moderna USD 10.96B 527M 2026-06
Neurocrine Biosciences USD 300K 2.6M 2026-09
Novartis USD 468M 6M 2026-09
Pfizer USD 662M 5M 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 3.37M 11K 2024-06
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sanofi EUR 222M 65M 2026-09
Sarepta Therapeutics USD 21.51M 205K 2026-06
Ultragenyx Pharmaceutical USD 20M 2M 2026-09
United Therapeutics USD 2.9M 0 2026-09
Vertex Pharmaceuticals USD 36M 32.7M 2026-09